JPS63264595A - Production of physiologically active substance from cork tree bark - Google Patents

Production of physiologically active substance from cork tree bark

Info

Publication number
JPS63264595A
JPS63264595A JP62095426A JP9542687A JPS63264595A JP S63264595 A JPS63264595 A JP S63264595A JP 62095426 A JP62095426 A JP 62095426A JP 9542687 A JP9542687 A JP 9542687A JP S63264595 A JPS63264595 A JP S63264595A
Authority
JP
Japan
Prior art keywords
adsorbent
extract
water
substance
physiologically active
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP62095426A
Other languages
Japanese (ja)
Inventor
Yutaka Hirayama
豊 平山
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Lion Corp
Original Assignee
Lion Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lion Corp filed Critical Lion Corp
Priority to JP62095426A priority Critical patent/JPS63264595A/en
Publication of JPS63264595A publication Critical patent/JPS63264595A/en
Pending legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61QSPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00Preparations for care of the skin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/96Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
    • A61K8/97Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
    • A61K8/9783Angiosperms [Magnoliophyta]
    • A61K8/9789Magnoliopsida [dicotyledons]

Abstract

PURPOSE:To readily obtain a substance, having excellent humectant effects, anti-inflammatory activity, etc., and useful as a blending component for cosmetics, etc., without a change of color, etc., with time, by adsorbing an extract of Cork tee bark on an adsorbent and eluting the adsorbed substance with water. CONSTITUTION:Cork tree bark which is dried tree bark of Phellodendron amurense and relative species or species of the same genus is extracted with water, hydrous alcohol or various organic solvents and the resultant extract is then brought into contact with an adsorbent in an amount of preferably 10-40 times. The adsorbed extract is subsequently eluted with water in an amount of preferably >=5 times based on the adsorbent to afford the aimed substance. Furthermore, a hydrophobic adsorbent, such as a porous polymer which is a polymer of styrene and divinylbenzene, is preferably used as the adsorbent.

Description

【発明の詳細な説明】 産 土の千1 本発明は、優れた保湿効果や抗炎症活性等の生理活性作
用を有し、かつ安定性の高いオウバクからの生理活性物
質の製造方法に関する。
DETAILED DESCRIPTION OF THE INVENTION The present invention relates to a method for producing a physiologically active substance from Auronicum spp., which has excellent moisturizing effects and physiologically active effects such as anti-inflammatory activity, and is highly stable.

丈来夏技左 周知のように、オウバク抽出物は保湿性や抗炎症活性等
の生理活性作用を有することから広く利用され、特に、
このオウバク抽出物は化粧料に配合したとき皮膚に弾力
や張りを与える上、安全性が高いことから各種化粧料に
有効であることが知られており、例えばオウバクの有機
溶媒抽出物を口臭や歯周病予防の有効成分として口腔用
組成物に配合したり(特開昭57−56415号)、オ
ウバクの乾留粉砕物を歯痛や歯周炎治療の有効成分とし
て歯周炎治療薬に配合すること(特開昭61−1222
21号)、界面活性剤にオウバクの含水アルコール抽出
物を配合して界面活性剤の有する皮膚に対する刺激性を
低下させること(特開昭60−56911号)、オウー
バクから生理活性成分のベルベリンを多く含有する水性
エキスの製造法(特公昭62−5890号)及びその水
性エキスを含有する皮膚外用剤(特公昭62−5891
号)、更にはオウバク抽出物を配合した保湿性化粧料(
特開昭60−258104号)等が提案されている。
As is well known, the extract of Aspergillus orientalis is widely used because it has physiologically active effects such as moisturizing properties and anti-inflammatory activity.
When added to cosmetics, this extract gives elasticity and tension to the skin, and is also highly safe, so it is known to be effective in various cosmetics. It is incorporated into oral compositions as an active ingredient for the prevention of periodontal disease (Japanese Patent Application Laid-open No. 57-56415), and the dry-distilled pulverized product of Aspergillus orientalis is incorporated into periodontitis therapeutics as an active ingredient for the treatment of toothache and periodontitis. (Japanese Unexamined Patent Publication No. 61-1222
No. 21), reducing the skin irritation of the surfactant by blending a hydroalcoholic extract of Aspergillus orientalis into a surfactant (Japanese Patent Application Laid-Open No. 60-56911), and adding a large amount of berberine, a physiologically active ingredient, from Aspergillus orientalis. A method for producing an aqueous extract containing the same (Japanese Patent Publication No. 62-5890) and a skin preparation for external use containing the aqueous extract (Japanese Patent Publication No. 62-5891)
(No.), as well as moisturizing cosmetics containing extract of Aspergillus orientalis (No.
Japanese Unexamined Patent Publication No. 60-258104) etc. have been proposed.

明が解3しようとする問題張 しかしながら、オウバク抽出物をそのまま化粧料に配合
すると、オウバク抽出物中の生理活性物質と称されるベ
ルベリン等の黄色成分が化粧料中の香料の影響で変色や
脱色を起こすという欠点があり、化粧料原料として好ま
しくな・い。
The problem that Ming is trying to solve 3: However, if the extract is added to cosmetics as it is, the yellow components such as berberine, which are called biologically active substances in the extract, will discolor or change color due to the influence of the fragrances in the cosmetics. It has the disadvantage of causing decolorization, making it undesirable as a raw material for cosmetics.

従って、安定な品質を有する生理活性物質を簡単に収率
良く製造する方法が望まれている。
Therefore, a method for easily producing physiologically active substances with stable quality and high yield is desired.

本発明は安定な品質を有する生理活性物質を簡単に製造
する方法を提供することを目的とする。
An object of the present invention is to provide a method for easily producing a physiologically active substance having stable quality.

司 1、を解 するための   び 本発明者らは上記目的を達成するため鋭意検討を重ねた
結果、オウバク抽出物を吸着剤、特に疎水性吸着剤で処
理する工程を行なった後、水で溶出させることにより、
オウバクからの生理活性物質が簡単な操作で得られるこ
と、しかも通常生理活性成分とされている黄色成分が上
記工程で除去されるにもかかわらず、優れた保湿効果や
抗炎症活性等の生理活性作用を有する粘液が得られる上
、この粘液は凍結乾燥後に水で再溶解しても変性してそ
の粘性や生理活性作用が低下することがなく、かつ上記
工程中に黄色物質が除去されるので、化粧料や外用剤等
に配合してもその色調が経時で変色又は脱色することが
なく、安定性に優れていると共に、手荒れ、肌荒れ等を
効果的に予防或いは改善し得、安全性も高く、従って、
この生理活性物質が化粧料、外用剤等に好適に配合され
ることを知見し、本発明をなすに至った。
In order to solve the problem 1, the inventors of the present invention have conducted intensive studies to achieve the above-mentioned objective, and as a result, after performing a process of treating the extract of Aspergillus orientalis with an adsorbent, especially a hydrophobic adsorbent, it was treated with water. By elution,
Physiologically active substances can be obtained from Auronicum spp. by a simple operation, and even though the yellow component, which is usually considered to be a bioactive ingredient, is removed in the above process, it has excellent moisturizing effect and anti-inflammatory activity. In addition to obtaining effective mucus, this mucus does not denature and lose its viscosity or physiological activity even if it is redissolved in water after freeze-drying, and the yellow substance is removed during the above process. Even when incorporated into cosmetics and external preparations, the color tone does not change or bleach over time, and it has excellent stability. It can also effectively prevent or improve rough hands and skin, and is safe. high, therefore
The present inventors have discovered that this physiologically active substance can be suitably incorporated into cosmetics, external preparations, etc., and have accomplished the present invention.

従って、本発明はオウバク抽出物を吸着剤で処理する工
程を行なった後、水で溶出させることにより得られる物
質を採取することを特徴とするオウバクからの生理活性
物質の製造方法を提供する。
Accordingly, the present invention provides a method for producing a physiologically active substance from Aspergillus orientalis, which comprises the steps of treating an extract of Aspergillus orientalis with an adsorbent and then eluting it with water to collect the resulting substance.

以下1本発明につき更に詳述する。The present invention will be explained in more detail below.

本発明のオウバクからの生理活性物質の製造方法におい
ては、その原料であるミカン科のキハダ及び近縁同属種
の樹皮乾燥物であるオウバクを水、含水メタノール等の
含水アルコール、種々の有機溶媒、例えばメタノール、
エタノール、アセトン。
In the method for producing a physiologically active substance from Auronicum of the present invention, the raw material, the dried bark of Auronicum amberjack of the Rutaceae family and a related species of the same genus, is mixed with water, a hydrous alcohol such as hydrous methanol, various organic solvents, For example, methanol,
ethanol, acetone.

クロロホルム、酢酸エチル、ブタノール、エーテル等で
抽出したオウバク抽出物を用い、まずこのオウバク抽出
物を吸着剤で処理する工程を行なう。
First, a step of treating this extract with an adsorbent is performed using an extract extracted with chloroform, ethyl acetate, butanol, ether, etc.

この場合、用いるオウバク抽出物に何ら制限はなく、オ
ウバクを含水アルコール等で抽出した抽出物やその濃縮
、乾固物を水に溶解したものを用いてもよいが、特にオ
ウバクの水抽出物をそのまま、又は適量に濃縮したもの
を用い、これを吸着剤で処理することが好ましい。
In this case, there is no restriction on the extract of Aspergillus orientalis to be used, and an extract obtained by extracting Aspergillus orensis with hydrous alcohol, etc., or its concentrated or dried product dissolved in water may be used, but in particular, an aqueous extract of Aspergillus orensis may be used. It is preferable to use it as it is or to concentrate it in an appropriate amount and treat it with an adsorbent.

更に、吸着処理する際の処理方法や条件は種々選択され
るが、特に吸着剤として疎水性吸着剤を用いることが好
ましい、ここで、疎水性吸着剤としてはスチレンの単量
体とジビニルベンゼンの単量体とを重合させることによ
り得られる多孔性ポリマーの球状樹脂が有効に使用でき
、この樹脂は表面が疎水性であることから疎水性塵の大
きな有機物をファンデルワールス力により吸着する能力
を有する。このような疎水性吸着剤樹脂として具体的に
は、アンバーライトXAD−2,XAD−4(ローム・
アンド・バー入社製)、ダイヤイオンHP−20,HP
−21(E菱化成社製)、セパビーズ5P−206,5
P−207(三菱化成社製)等が例示される。
Furthermore, various treatment methods and conditions can be selected for the adsorption treatment, but it is particularly preferable to use a hydrophobic adsorbent as the adsorbent. Porous polymer spherical resin obtained by polymerizing monomers can be effectively used, and since this resin has a hydrophobic surface, it has the ability to adsorb large hydrophobic particles of organic matter by van der Waals force. have Specifically, such hydrophobic adsorbent resins include Amberlite XAD-2, XAD-4 (ROHM
(Manufactured by & Bar), Diaion HP-20, HP
-21 (manufactured by E-Ryo Kasei Co., Ltd.), Sepa beads 5P-206,5
P-207 (manufactured by Mitsubishi Kasei Corporation) is exemplified.

また、吸着剤の使用量は用いるオウバク抽出物量に応じ
適宜選択されるが、オウバク抽出物を十分吸着処理し得
る吸着剤量、即ち、少なくてもオウバク抽出物に対して
5倍量以上(抽出物100gに対して吸着剤500d)
、特に10〜40倍量の範囲とすることが望ましい。
In addition, the amount of adsorbent to be used is appropriately selected depending on the amount of Aspergillus asparagus extract to be used, but the amount of adsorbent that can sufficiently adsorb the Aspergillus asparagus extract, that is, at least 5 times the amount of Aspergillus asparagus extract (extracted 500 d of adsorbent for 100 g of material)
In particular, it is desirable that the amount be in the range of 10 to 40 times.

次いで、本発明においては、上述の如くオウバク抽出物
を吸着剤に通して処理した後、この吸着剤から水で溶出
される物質を採集する。
Next, in the present invention, after treating the extract of Aspergillus orientalis by passing it through an adsorbent as described above, the substance eluted from the adsorbent with water is collected.

ここで、溶出方法は通常の方法を採用し得、例えば室温
で吸着剤に水を除々に通すことにより目的とする生理活
性作用を有する粘液質の水溶液を得ることができる。
Here, the elution method can be a conventional method, for example, by gradually passing water through an adsorbent at room temperature, a mucilage aqueous solution having the desired physiologically active action can be obtained.

なお、溶出に用いる水の溶出液量は、吸着剤樹脂量の2
倍量以上、特に5倍量以上が好ましい。
Note that the amount of water used for elution is 2 times the amount of adsorbent resin.
The amount is preferably 5 times or more, particularly 5 times or more.

このようにして水で溶出させることにより得られた物質
は、配合すべき製品等に応じ、溶媒を留去せずに、又は
一部もしくは全部を留去して使用することができる。
The substance thus obtained by elution with water can be used without distilling off the solvent, or after partially or completely distilling off the solvent, depending on the product to be blended.

本発明のオウバクからの生理活性物質の製造方法により
得られた物質は、保湿効果や抗炎症活性等の生理活性作
用に優れ、各種化粧料や外用剤など皮膚の保湿性を保っ
て手荒れや肌荒れを予防又は改善したり、皮膚炎等を予
防する製品に配合して広く利用することができる。なお
1本発明生理活性物質を各種化粧料や外用剤などに配合
する場合、その配合量は製品全体の0.01〜50%(
重量%)とすることが好ましい。
The substance obtained by the method for producing a physiologically active substance from Auronicum spp. of the present invention has excellent physiologically active effects such as moisturizing effect and anti-inflammatory activity, and can be used in various cosmetics and external preparations to maintain skin moisturizing properties and prevent rough hands and skin. It can be widely used by being incorporated into products to prevent or improve skin irritation, or to prevent dermatitis, etc. Note that when the physiologically active substance of the present invention is blended into various cosmetics and external preparations, the amount of the present invention is 0.01 to 50% of the total product (
% by weight).

見所立麦困 以上説明したように1本発明のオウバクからの生理活性
物質の製造方法によれば、保湿効果や抗炎症活性等の生
理活性作用に優れた物質を簡単に得ることができる。更
に、本発明製造方法で得られる生理活性物質は、凍結乾
燥後に水で再溶解しても変性してその粘性や生理活性作
用が低下することがない上、化粧料等に配合してもその
色調が経時で変化することがなく、安定性に優れ、かつ
安全性も高いので、各種化粧料や外用剤など皮膚の保湿
性を保って手荒れや肌荒れを予防又は改善したり、皮膚
炎等を予防する製品に配合して広く利用することができ
る。
Highlights As explained above, according to the method for producing a physiologically active substance from Auronicum oleracea of the present invention, a substance with excellent physiologically active effects such as moisturizing effect and anti-inflammatory activity can be easily obtained. Furthermore, the physiologically active substance obtained by the production method of the present invention does not denature and lose its viscosity or physiological activity even if it is redissolved in water after freeze-drying, and it does not deteriorate when incorporated into cosmetics etc. The color tone does not change over time, it is highly stable, and it is also highly safe, so it can be used as a variety of cosmetics and external preparations to keep the skin moisturized, prevent or improve rough hands and skin, and treat dermatitis, etc. It can be widely used by incorporating it into preventive products.

以下に実施例及び実験例を示し、本発明を具体的に説明
するが、本発明は下記実施例に制限されるものではない
EXAMPLES The present invention will be specifically explained below with reference to Examples and Experimental Examples, but the present invention is not limited to the Examples below.

〔実施例〕〔Example〕

オウバク水抽出液2Ω (オウバク末200gに相当)
をIQのアンバーライトXAD−2樹脂(ローム・アン
ド・ハース社製)に通した後、約5Qの水で溶出させて
水溶出部を得た。得られた水溶出部を凍結乾燥すること
により、白色〜クリーム色の粘液物質を得た(収率1o
%)。
2Ω of Auronicum water extract (equivalent to 200g of Auronicum powder)
was passed through IQ's Amberlite XAD-2 resin (manufactured by Rohm and Haas) and eluted with about 5Q of water to obtain a water-eluted portion. By freeze-drying the obtained aqueous eluate, a white to cream-colored mucous substance was obtained (yield: 10
%).

〔実験例1〕 実施例で得られた粘液物質を用いて下記処方の軟膏を調
製した。
[Experimental Example 1] An ointment having the following formulation was prepared using the mucus substance obtained in the example.

監」冒(方 白色ワセリン          250gステアリル
アルコール       220プロピレングリコール
       120ラウリル硫酸ナトリウム    
   15オウバク粘液(本発明品)        
10パラオキシ安息香酸プロピル      0.15
精  製  氷              残金  
量               100.0g上記本
発明品配合軟膏と、上記と同処方で本発明品を含まない
軟膏基剤とを検体として用い、下記方法で各検体の保湿
効果を測定した。
White petrolatum 250g Stearyl alcohol 220 Propylene glycol 120 Sodium lauryl sulfate
15 Aurubaku mucus (product of the present invention)
10 paraoxybenzoic acid propyl 0.15
Refined ice balance
Amount: 100.0g The above ointment containing the present invention product and an ointment base having the same formulation as above but not containing the present invention product were used as specimens, and the moisturizing effect of each specimen was measured by the following method.

保 効果の 価゛ 石けんで前腕内側部を繰返し洗浄して作成した肌荒れモ
デル(モデル数8)に検体を各々連続塗布し、検体塗布
前と塗布2日目の電導塵を高周波インピーダンス法で測
定した。
The test sample was continuously applied to rough skin models (8 models) created by repeatedly washing the inner side of the forearm with soap, and conductive dust was measured using a high-frequency impedance method before and on the second day of application. .

結果を図に示す。The results are shown in the figure.

なお、図中横軸のインピーダンス測定日の0は検体塗布
直前を示し、2は検体連続塗布2日目を示す。
Note that 0 on the impedance measurement date on the horizontal axis in the figure indicates immediately before sample application, and 2 indicates the second day of continuous sample application.

また、図中Aは本発明品配合軟膏投与群、Bは軟膏基剤
投与群、Cは無処理を示す。
Further, in the figure, A indicates a group administered with an ointment containing the product of the present invention, B indicates a group administered with an ointment base, and C indicates no treatment.

図から明らかなように、本発明品配合軟膏塗布群の平均
型導度は、軟膏基剤塗布群や無処理群に比べて高く、本
発明品が保湿効果に優れていることが確認された。
As is clear from the figure, the average mold conductivity of the ointment application group containing the present invention product was higher than that of the ointment base application group and the untreated group, confirming that the invention product has an excellent moisturizing effect. .

〔実験例2〕 体重220gのウィスター系雌ラットの血液をエーテル
麻酔下で採血し、採取した血液をリン酸緩衝液で4回洗
浄した後回液で希釈し、赤血球数1 、 OX 10 
’cells/ mQとなるように調整し、これを赤血
球懸濁液として用いた。
[Experimental Example 2] Blood was collected from a Wistar female rat weighing 220 g under ether anesthesia, and the collected blood was washed 4 times with phosphate buffer, diluted with the washing solution, and the number of red blood cells was 1 and OX 10.
'cells/mQ, and this was used as a red blood cell suspension.

上記赤血球懸濁液0.2dに、実施例で得られた粘液物
質(本発明品)を検体として溶解した低張の0.32N
a(l含有10mMリン酸緩衝液(pH7,4)4.8
dを混合し、30分間室温にて放置した後、200Or
pmで10分間遠心分離した。
A hypotonic 0.32N solution containing the mucus substance obtained in the example (product of the present invention) as a specimen was dissolved in 0.2 d of the above red blood cell suspension.
a (10mM phosphate buffer (pH 7,4) containing 4.8
After mixing d and leaving it at room temperature for 30 minutes, 200 Or
Centrifuged at pm for 10 minutes.

上澄液を採取し、波長540nmにおける吸光度を測定
して下記式に基いて溶血抑制率を算出した。
The supernatant was collected, the absorbance at a wavelength of 540 nm was measured, and the hemolysis inhibition rate was calculated based on the following formula.

なお、比較のため検体としてオウバク水抽出エキスを用
い、上記と同様の方法で溶血抑制率を求めた。
For comparison, the hemolysis inhibition rate was determined in the same manner as described above using a water extract of Laminaria japonica as a specimen.

結果を第1表に示す。The results are shown in Table 1.

第  1  表 第1表の結果より、本発明品のオウバク粘液物質は、溶
血抑制率が高く、抗炎症作用に優れていることが確認さ
れた。
Table 1 From the results shown in Table 1, it was confirmed that the mucilage substance of the present invention has a high hemolysis suppression rate and is excellent in anti-inflammatory action.

以下に本発明品の配合例を示す。なお、以下%はいずれ
も重量%を示す。
Examples of formulations of the products of the present invention are shown below. Note that all percentages hereinafter indicate weight percentages.

〔配合例1〕 ステアリン酸                2.0
%ステアリルアルコール            7.
0還元ラノリン                 2
.0スクワラン                 5
.0オクチルドデカノール            6
.0親油型モノステアリン酸グリセリン     2.
0オウバク粘液(本発明品)1.0 香    料                  0
.3防腐剤      微量 プロピレングリコール            5.0
計                      10
0.0%〔配合例2〕 酢酸dQ−α−トコフェロール         0.
2%流動パラフィン               9
.0パラフイン                  
1.0パルミチン酸イソプロピル          
3.0セタノール                 
 3.0ステアリン酸               
 3.0親油型モノステアリン酸グリセリン     
 2.0パラオキシ安息香酸ブチル         
0.1パラオキシ安息香酸メチル         0
.2オウバク粘液(本発明品)1.0 着香料      微量 精 製 水          バランス
[Formulation example 1] Stearic acid 2.0
% stearyl alcohol 7.
0 reduction lanolin 2
.. 0 squalane 5
.. 0 octyldodecanol 6
.. 0 lipophilic type glyceryl monostearate 2.
0 Auricular mucus (product of the present invention) 1.0 Fragrance 0
.. 3 Preservative Trace amount of propylene glycol 5.0
Total 10
0.0% [Formulation Example 2] dQ-α-tocopherol acetate 0.
2% liquid paraffin 9
.. 0 paraffin
1.0 Isopropyl palmitate
3.0 cetanol
3.0 stearic acid
3.0 Lipophilic glyceryl monostearate
2.0 Butyl paraoxybenzoate
0.1 Methyl paraoxybenzoate 0
.. 2 Amber mucus (product of this invention) 1.0 Flavoring agent Micro-purification Water Balance

【図面の簡単な説明】[Brief explanation of drawings]

図面は、保湿効果の評価における検体塗布前後の平均型
導度を示すグラフである。 出願人  ラ イ オ ン 株式会社 代理人  弁理士  小 島 隆 司 (Ω) インピーダンス測定日
The figure is a graph showing the average type conductivity before and after application of the sample in the evaluation of moisturizing effect. Applicant Lion Co., Ltd. Agent Patent Attorney Takashi Kojima (Ω) Impedance measurement date

Claims (1)

【特許請求の範囲】 1、オウバク抽出物を吸着剤で処理する工程を行なった
後、水で溶出させることにより得られる物質を採取する
ことを特徴とするオウバクからの生理活性物質の製造方
法。 2、吸着剤が疎水性吸着剤である特許請求の範囲第1項
記載の製造方法。
[Scope of Claims] 1. A method for producing a physiologically active substance from Aspergillus orientalis, which comprises performing a step of treating an extract of Aspergillus orientalis with an adsorbent, and then collecting a substance obtained by eluting it with water. 2. The manufacturing method according to claim 1, wherein the adsorbent is a hydrophobic adsorbent.
JP62095426A 1987-04-20 1987-04-20 Production of physiologically active substance from cork tree bark Pending JPS63264595A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP62095426A JPS63264595A (en) 1987-04-20 1987-04-20 Production of physiologically active substance from cork tree bark

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP62095426A JPS63264595A (en) 1987-04-20 1987-04-20 Production of physiologically active substance from cork tree bark

Publications (1)

Publication Number Publication Date
JPS63264595A true JPS63264595A (en) 1988-11-01

Family

ID=14137369

Family Applications (1)

Application Number Title Priority Date Filing Date
JP62095426A Pending JPS63264595A (en) 1987-04-20 1987-04-20 Production of physiologically active substance from cork tree bark

Country Status (1)

Country Link
JP (1) JPS63264595A (en)

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2841133A1 (en) * 2002-06-25 2003-12-26 Vincience Cosmetic or pharmaceutical composition useful for treating or preventing symptoms of skin aging and improving the appearance of the skin comprises a cork extract
JP2004010503A (en) * 2002-06-04 2004-01-15 Ogawa & Co Ltd Moisture-retaining plant extract and moisture-retaining external preparation containing the extract, cosmetic, bathing agent and detergent composition
WO2015152746A1 (en) * 2014-04-01 2015-10-08 Amorim Cork Research, Lda. Cork hydroglycolic extract, method for preapring same, formulations comprising said extract and use thereof

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2004010503A (en) * 2002-06-04 2004-01-15 Ogawa & Co Ltd Moisture-retaining plant extract and moisture-retaining external preparation containing the extract, cosmetic, bathing agent and detergent composition
FR2841133A1 (en) * 2002-06-25 2003-12-26 Vincience Cosmetic or pharmaceutical composition useful for treating or preventing symptoms of skin aging and improving the appearance of the skin comprises a cork extract
WO2015152746A1 (en) * 2014-04-01 2015-10-08 Amorim Cork Research, Lda. Cork hydroglycolic extract, method for preapring same, formulations comprising said extract and use thereof

Similar Documents

Publication Publication Date Title
JP3264934B2 (en) Polyphenol fraction of tea, its use, and formulations containing it
JP2002507575A (en) Use of at least one protein extract of Moringa plant seeds and corresponding cosmetic and / or pharmaceutical compositions
JPS6137896B2 (en)
EP0810222B1 (en) Process for extraction of polyphenolic compounds of catechin type from plants, the so obtained extract and its use
WO1998031336A1 (en) Use of an extract of the genus adansonia
JPH115975A (en) Active oxygen scavenger and use thereof
JPH05503915A (en) Composition for the treatment of oily or fatty skin secretions
JPH0237884B2 (en)
JPS5916814A (en) Composition for oral cavity
JPS63264595A (en) Production of physiologically active substance from cork tree bark
JP3977889B2 (en) Drugs containing buckwheat husk extract as an active ingredient
JPS5913716A (en) Composition for external use
JP5067916B2 (en) Skin cosmetics and hair cosmetics
US20060024247A1 (en) Oral care formulations comprising highly bioavailable Coenzyme Q-10 cyclodextrin complex
JPS6136215A (en) Composition for oral cavity application
JP2005263655A (en) Antioxidant
JPH0310609B2 (en)
JPH0314283B2 (en)
JP2000212058A (en) Skin cosmetic, active oxygen eliminator, esterase inhibitor, and collagenase inhibitor
JP4197194B2 (en) Oral administration agent for intercellular adhesion suppression
JP3961129B2 (en) Purification method of seaweed extract
JPS63264529A (en) Production of antiphlogistics from phellodendri cortex
KR0180689B1 (en) Skin whitening composition
JP3281716B2 (en) Glucosyltransferase inhibitors, oral preparations and foods and drinks
JPH10120522A (en) Purification of seaweed extract and cosmetic